- Reframe Daily
- Archive
- Page 7
Past Issues
Reframe Daily: Superbug vaccine, tarlatamab survival boost, simpler cancer care, clearer kid vision, & microbiome defense—5 July 24 breakthroughs
Inside: a once-weekly shot that shielded mice from drug-resistant Pseudomonas, a targeted lung-cancer drug that beats chemo, a shorter chemo-radiation schedule that spares nasopharyngeal patients months of side-effects, a night-lens–atropine combo that slows kids’ myopia, and a one-time microbiome transplant that cuts superbugs in long-term antibiotic users.
Reframe Daily: Malaria-blocking ivermectin, direct-text gene alerts & 3 more breakthroughs—your July 23 health roundup
A once-a-month ivermectin dose cut malaria cases in 20,000 kids, clinic-to-family texts doubled DNA testing, a cholesterol pill super-charged brain-tumor chemo in mice, a light-based ear scan sped hearing-loss diagnosis, and daily baby lotion slashed eczema risk—read the quick hits inside.
Reframe Daily: Antibody enables chemo-free bone-marrow transplants—plus 4 more July 22 breakthroughs
Radiation-sparing Fanconi anemia transplant, a newly revealed psoriasis enzyme target, seizure-triggering RNA tag uncovered, bone-building hormone switch, and a microbiome test that predicts which malnourished children rebound fastest—dive into five peer-reviewed advances from 7/22/25 in under two minutes.
Reframe Daily: Semaglutide reverses liver scarring; new orexin pill boosts alertness; HER2 “two-handed” drug shrinks tumors fast
Plus: aggressive chemo-rituximab combo leaves mantle-cell-lymphoma patients cancer-free for nearly 20 years—get the week’s breakthrough data in 2 minutes.
Reframe Daily: Once-a-week insulin confirmed, AI spots sepsis in seconds—5 health breakthroughs inside
Phase-3 trial proves weekly insulin works, handheld light scanner diagnoses sepsis on the spot, open-source “AI doctor” rivals pricey systems, blood-donor test tracks new COVID strains cheaply, and self-assembling nanofibers wipe out stubborn bacteria—read the quick rundown.
Reframe Daily: Same-Day Cancer Test, Inhaled COVID Shield, and More Breakthrus
A single-tube RNA test helps oncologists choose drugs in hours, a “two-headed” antibody spray clears Omicron faster, AI rescues an Alzheimer’s drug, four weeks of cycling rejuvenates older hearts and brains, and a tiny stress RNA hints at stopping kidney failure—scan the details in one quick read.
RD: Three-Parent IVF Success, Restarted Donor Heart, Christin's Dream for Reframe
Babies protected from mitochondrial disease, stopped hearts revived for life-saving transplants, a low-cost bone drug eases stubborn nerve pain, and a 30-second breath test flags post-COVID lung scarring—scan the details in one quick read.
RD: Interchangeable cheaper insulin hits U.S. shelves and more + your exclusive access to the Reframe Community
The FDA-cleared Kirsty biosimilar that could drop NovoLog prices, GLP-1 shots shown to cut dementia and stroke risk, a combo PTSD-plus-alcohol program halving symptoms, plug-and-play software that trims needless scans, and the antibody that saved monkeys from yellow fever + your exclusive early access to the Reframe Community
Reframe Daily: kidney-safe hyperbaric therapy; gene “wake-up” drug, low-dose CT AI, quantum heart screen & nano lung therapy - and a new book by a self taught geneticist
New data clears HBOT for renal safety, a gene-wake drug shows promise in Angelman kids, AI makes low-dose CT scans crystal clear, hybrid quantum tech spots heart risk earlier, and nano-packets steer everyday meds straight to lung tumors—open for the full rundown.
RD: AI reads cancer slides, blood test spots early aging, gentler Alzheimer’s dosing, rare-disease turnaround, and a robot surgeon’s first solo move
Lung-cancer slides decoded by AI, simple blood tests that predict long life, a kid walking after a rare brain illness, the FDA’s friendlier Kisunla plan, and the first autonomous step in gallbladder surgery—catch today’s good-health wins in two minutes.